Literature DB >> 7917158

Comparative effects of quinapril, atenolol, and verapamil on blood pressure and forearm hemodynamics during handgrip exercise.

J Cléroux1, M Beaulieu, N Kouamé, Y Lacourcière.   

Abstract

We compared the effects of angiotensin-converting enzyme inhibition with quinapril to those of selective beta-blockade with atenolol and calcium channel blockade with verapamil in 10 hypertensive subjects in a randomized double-blind placebo-controlled crossover study. All antihypertensive agents reduced baseline mean arterial pressure equally and did not modify forearm vascular resistance compared to placebo. In response to sustained handgrip exercise, both quinapril and verapamil, but not atenolol, attenuated the pressor response. However, verapamil was associated with an exaggerated increase in forearm vascular resistance during handgrip, whereas quinapril did not alter this response compared to placebo. It is concluded that quinapril and verapamil reduce the pressor response during isometric exercise by quantitatively different effects on the vasoconstrictor response in, as well as outside of, skeletal muscles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917158     DOI: 10.1093/ajh/7.6.566

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

1.  Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives.

Authors:  Ricardo S Gomides; Luiz A R Costa; Dinoélia R Souza; Andréia C C Queiroz; João R C Fernandes; Kátia C Ortega; Décio Mion Junior; Taís Tinucci; Cláudia L M Forjaz
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

2.  Contrasting effects of verapamil and amlodipine on cardiovascular stress responses in hypertension.

Authors:  J D Lefrandt; J Heitmann; K Sevre; M Castellano; M Hausberg; M Fallon; A Urbigkeit; M Rostrup; E Agabiti-Rosei; K H Rahn; M Murphy; F Zannad; P J de Kam; A J Smit
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

3.  Functional sympatholysis is impaired in hypertensive humans.

Authors:  Wanpen Vongpatanasin; Zhongyun Wang; Debbie Arbique; Gary Arbique; Beverley Adams-Huet; Jere H Mitchell; Ronald G Victor; Gail D Thomas
Journal:  J Physiol       Date:  2011-01-04       Impact factor: 5.182

Review 4.  Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension.

Authors:  Balraj S Heran; Michelle My Wong; Inderjit K Heran; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.